Susquehanna Foundation
EndowmentClone Performance
Aug 2023–Apr 2025 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 100% of reported value on average across 6 quarters.Susquehanna Foundation has stopped filing, so the simulation ends in Apr 2025 — where its last reported portfolio went stale — rather than trading that portfolio forward to today. Past performance does not predict future results.
Portfolio Concentration
3 tracked positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Portfolio Trend
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 99.5% | $330,197,348 |
| Basic Materials | 0.5% | $1,508,130 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedTrimmed
Positions the filer reducedNew Positions
Positions the filer opened this quarterSold Out
Positions the filer fully exited| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
Held | 673,923 | $328,921,598 | 99.16% | |
| CC |
Chemours Co
Basic Materials
|
Held | 74,219 | $1,508,130 | 0.45% | |
| VEU |
Vanguard FTSE All-World Ex-US ETF
|
Held | 20,250 | $1,275,750 | 0.38% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.